Day 2: Thursday, September 24
Day 2: Thursday, September 24
06:45 - 07:4560 mins
Biotech Week Boston 2026 Fun Run
08:30 - 08:5525 mins
Morning Registration & Breakfast
08:55 - 09:005 mins
INNOVATION SPOTLIGHT
Chair
09:00 - 09:2020 mins
INNOVATION SPOTLIGHT
Targeting Fibroinflammation to Modify Cardiorenal-Metabolic Disease in the Post-GLP-1 Era
- Laurent Audoly - CEO, Prive Bio
09:20 - 09:4020 mins
INNOVATION SPOTLIGHT
Small Molecule Agonism of the Apelin Pathway as a Novel Exercise Mimetic Strategy
- Peng Leong - CBO, BioAge Labs
09:40 - 10:0020 mins
INNOVATION SPOTLIGHT
A Novel Oral Glucose-Based Approach to Restore Nutrient Sensing and Neuroendocrine Signaling in Obesity
- Steffen-Sebastian Bolz - CSO, Aphaia Pharma AG
10:00 - 10:2020 mins
INNOVATION SPOTLIGHT
First-in-Class Small Molecule Targeting Adipocyte Futile Cycling for Weight Loss
- Joanne Hsieh, PhD - Head of Metabolism, Gordian Biotechnology
10:20 - 10:5030 mins
Morning Refreshment Break
10:50 - 11:1020 mins
INNOVATION SPOTLIGHT
Spotlight Presentation Opportunity Available
11:10 - 11:3020 mins
INNOVATION SPOTLIGHT
Leveraging Site-Specific Modifications to Create Next Generation GLP-1 Peptides
- Saleha Patel - Head of Pipeline and Commercialization Strategy, Constructive Bio
11:30 - 11:5525 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
Oral Selective Androgen Receptor Modulation for Muscle Preservation in GLP-1 Patients
- Mitchell Steiner, MD - President and Chief Executive Officer, VERU
11:55 - 12:2025 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
A Precision Antibody Approach to Maximise Weight-Loss and Muscle Mass Preservation
- Tom Hsu - Scientist, Ibio
12:20 - 13:3575 mins
Lunch Break
13:35 - 13:405 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
Chair
13:40 - 14:0525 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
Investigating Anti-Myostatin + Anti-Activin A for Obesity
14:05 - 14:3025 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
Presentation Reserved For Partner
14:30 - 14:5525 mins
GLP-1s BEYOND OBESITY
Future Role of GLP-1-Based Therapeutics in Neuroprotection
- Paul Edison - Professor of Neuroscience, UCL
14:55 - 15:2025 mins
GLP-1s BEYOND OBESITY
Presentation: Beyond Weight Loss: Evaluating GLP-1 Based Therapies across Diverse Cardiometabolic Animal Models
- Rana Assaly - Director, Scientific & Business Development, Cardiomedex
- Francois Briand - Director Research & Development, Physiogenex
15:20 - 15:4525 mins
GLP-1s BEYOND OBESITY
Unique Targeting Of The Gut For Metabolic Benefit and Beyond
- David Pass - CEO, Altrix Bio
15:45 - 16:2540 mins
Afternoon Refreshment Break
16:25 - 17:1550 mins
CLOSING KEYNOTE PLENARY
Keynote Panel: Breaking Barriers: Addressing Pricing and Reimbursement Challenges in Obesity Therapeutics
- Mimoun Ayoub, PhD - Senior VP, Global Head of Peptide and Oligonucleotide Platforms, CordenPharma International
- Laurent Audoly - CEO, Prive Bio
- Joseph Zucchi - Board Member/Physician Associate, New England Obesity Society/ Transition Medical Weight Loss
- Millie Hoe - Life Science Reporter, Bioxconomy, Informa Connect
17:15 - 17:205 mins
CLOSING KEYNOTE PLENARY
Chair Closing Remarks
17:20 - 17:3010 mins
Close of Obesity Science & Innovation 2026
17:30 - 18:0030 mins
Coaches to Networking Party
18:00 - 21:30210 mins
2026 BWB Museum of Science Networking Party
Biotech Week Boston Party at the Museum of Science
* 活动内容有可能不事先告知作更动及调整。